Dogan, I. Et Al. 2023. Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process. ONCOLOGY , vol.101, no.4 , 262-269.

Dogan, I., Kizildag, İ., Özkurt, S., Ibis, K., Vatansever, S., Saip, P., ... Aydiner, A.(2023). Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process. ONCOLOGY , vol.101, no.4, 262-269.

Dogan, Izzet Et Al. "Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process," ONCOLOGY , vol.101, no.4, 262-269, 2023

Dogan, Izzet Et Al. "Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process." ONCOLOGY , vol.101, no.4, pp.262-269, 2023

Dogan, I. Et Al. (2023) . "Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process." ONCOLOGY , vol.101, no.4, pp.262-269.

@article{article, author={Izzet Dogan Et Al. }, title={Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process}, journal={ONCOLOGY}, year=2023, pages={262-269} }